Vice President
Opthamology
Oraclinical
United States of America
12+ years of executing ophthalmic preclinical, clinical, regulatory strategy and full clinical execution of programs across a number of therapeutic areas, including glaucoma, retina, and inflammation
His research interest in ophthalmology and clinical trials ,including glaucoma, retina, and inflammation